These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6976915)

  • 1. Role of autologous lymphocyte cytotoxicity in colonic neoplasia.
    Gallagher P; Vose BM; Moore M; Schofield PF
    Gut; 1982 Jan; 23(1):31-5. PubMed ID: 6976915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific and non-specific lymphocyte cytotoxicity in colon carcinoma.
    Vose BM; Gallagher P; Moore M; Schofield PF
    Br J Cancer; 1981 Dec; 44(6):846-55. PubMed ID: 6976792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of autologous T-cell anti-tumour responses in colon-carcinoma patients following active specific immunization (ASI).
    Patel BT; Lutz MB; Schlag P; Schirrmacher V
    Int J Cancer; 1992 Jul; 51(6):878-85. PubMed ID: 1639535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of regional lymph node in vitro antitumor immunoreactivity histology with colorectal carcinoma.
    Pihl E; Nairn RC; Nind AP; Muller HK; Hughes ES; Cuthbertson AM; Rollo AJ
    Cancer Res; 1976 Oct; 36(10):3665-71. PubMed ID: 1085194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cultured human T-cell lines kill autologous solid tumours.
    Vose BM; Moore M
    Immunol Lett; 1981 Oct; 3(4):237-41. PubMed ID: 6975752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cell activity and autologous mixed lymphocyte response of splenic, mesenteric lymph node, and colonic lymphocytes during DMH-induced colon carcinogenesis in the rat.
    Locniskar M; Nauss KM; Newberne PM
    Dig Dis Sci; 1987 Jul; 32(7):747-52. PubMed ID: 2954798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human tumour--lymphocyte interaction in vitro. V. Comparison of the reactivity of tumour-infiltrating, blood and lymph-node lymphocytes with autologous tumour cells.
    Vose BM; Vánky F; Klein E
    Int J Cancer; 1977 Dec; 20(6):895-902. PubMed ID: 591128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node anti-tumour effector cell mechanisms in colorectal carcinoma.
    Werkmeister JA; Pihl E; Flannery GR
    Aust J Exp Biol Med Sci; 1981 Apr; 59(Pt 2):115-24. PubMed ID: 7259635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactivity by intrinsic lymphoid cells in colorectal carcinoma.
    Werkmeister JA; Pihl E; Nind AP; Flannery GR; Nairn RC
    Br J Cancer; 1979 Dec; 40(6):839-47. PubMed ID: 316708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte anergy in patients with carcinoma.
    Nind AP; Nairn RC; Rolland JM; Guli EP; Hughes ES
    Br J Cancer; 1973 Aug; 28(2):108-17. PubMed ID: 4581078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro generation of tumour-specific lymphocyte reactivity to colonic carcinoma cells. Comparison with normal colonic mucosa cells.
    Kuppner M; Wilkinson S; Casson E; Eremin O
    Cancer Immunol Immunother; 1987; 25(3):209-14. PubMed ID: 3499984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of lymphocytes from blood, tumour and regional lymph nodes against K562 cells and autoplastic colorectal tumour cells.
    Hutchinson GH; Symes MO; Williamson RC
    Br J Cancer; 1982 Oct; 46(4):682-6. PubMed ID: 6958310
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumour-associated proliferative responses in vitro of regional lymph nodes draining solid cancers in man.
    Mainou-Fowler T; Eremin O
    Cancer Immunol Immunother; 1989; 30(5):300-6. PubMed ID: 2533881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of inhibition of lymphocyte cytotoxicity in human colon carcinoma.
    Nind AP; Matthews N; Pihl EA; Rolland JM; Nairn RC
    Br J Cancer; 1975 Jun; 31(6):620-9. PubMed ID: 51647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-infiltrating lymphocytes from human colon carcinomas. Functional and phenotypic characteristics after long-term culture in recombinant interleukin 2.
    Yoo YK; Heo DS; Hata K; Van Thiel DH; Whiteside TL
    Gastroenterology; 1990 Feb; 98(2):259-68. PubMed ID: 2295382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
    Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
    Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.
    Uchida A; Klein E
    J Natl Cancer Inst; 1986 Mar; 76(3):389-98. PubMed ID: 2419621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in circulating lymphocyte number and function after circulation through colorectal carcinomas.
    Rigg KM; Shenton BK; Brotherick I; Taylor RM; Lennard TW
    Surgery; 1991 Jun; 109(6):747-55. PubMed ID: 2042094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.
    Weidmann E; Logan TF; Yasumura S; Kirkwood JM; Trucco M; Whiteside TL
    Cancer Res; 1993 Oct; 53(20):4745-9. PubMed ID: 8402652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
    Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.